Opinions
Jim Cramer - Mad Money
Emergent BioSolutions
EBS-N
BUY
Jan 11, 2021
$98.890
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
SELL
A disaster. He feels bad for J&J that they ever signed a contract with them.
biotechnology
pharmaceutical
Advertising
Instead of buying a single vaccine-making pharma, consider this. They have an established vaccine business and are working on plasma-based treatments for Covid. They also have a big contract manufacturing business of vaccines with JNJ, AZN and Novavax. This has fallen $40 from its August peak. But last night they issued bullish future numbers for this year, and the stock jumped 4.7% today. More upside to come.